Targeting Alpha-Synuclein as a Therapy for Parkinson's Disease. (2019)
Attributed to:
Protection of neurons in vitro and in vivo from Synuclein toxicity by molecular tweezers
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fnmol.2019.00299
PubMed Identifier: 31866823
Publication URI: http://europepmc.org/abstract/MED/31866823
Type: Journal Article/Review
Volume: 12
Parent Publication: Frontiers in molecular neuroscience
ISSN: 1662-5099